Siglec-G deficiency leads to autoimmunity in aging C57BL/6 mice

Journal of Immunology

Volumn 195, Issue 1, 2015, Pages 51-60

  Müller, Jennifer ^a   Lunz, Benjamin ^a   Schwab, Inessa ^a   Acs, Andreas ^a   Nimmerjahn, Falk ^a   Daniel, Christoph ^a   Nitschke, Lars ^a  

^a UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; FC RECEPTOR IIB; SIALIC ACID BINDING IMMUNOGLOBULIN LIKE LECTIN; SIGLEC G; UNCLASSIFIED DRUG; FC RECEPTOR; FCGR2B PROTEIN, MOUSE; LECTIN; LYMPHOCYTE ANTIGEN RECEPTOR; SIGLECG PROTEIN, MOUSE;

AGING; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY PRODUCTION; ANTIBODY TITER; ARTICLE; AUTOIMMUNITY; B LYMPHOCYTE; CD4+ T LYMPHOCYTE; CONTROLLED STUDY; GERMINAL CENTER; GLOMERULONEPHRITIS; IMMUNOLOGICAL TOLERANCE; LYMPHOCYTE COUNT; MOUSE; NONHUMAN; PLASMA CELL; PRIORITY JOURNAL; ANIMAL; BIOSYNTHESIS; C57BL MOUSE; CROSS BREEDING; DEFICIENCY; FEMALE; GENE EXPRESSION; GENETICS; IMMUNOLOGY; KNOCKOUT MOUSE; MALE; MURPHY ROTHS LARGE LYMPHOPROLIFERATIVE MOUSE; PATHOLOGY;

AGING; ANIMALS; AUTOANTIBODIES; AUTOIMMUNITY; B-LYMPHOCYTES; CD4-POSITIVE T-LYMPHOCYTES; CROSSES, GENETIC; FEMALE; GENE EXPRESSION; GERMINAL CENTER; GLOMERULONEPHRITIS; IMMUNE TOLERANCE; LECTINS; MALE; MICE; MICE, INBRED C57BL; MICE, INBRED MRL LPR; MICE, KNOCKOUT; RECEPTORS, ANTIGEN, B-CELL; RECEPTORS, IGG;

EID: 84932164808     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1403139     Document Type: Article

References (57)

1. Tiegs, S. L., D. M. Russell, and D. Nemazee. 1993. Receptor editing in selfreactive bone marrow B cells. J. Exp. Med. 177: 1009-1020.
2. Müller, J., and L. Nitschke. 2014. The role of CD22 and Siglec-G in B-cell tolerance and autoimmune disease. Nat Rev Rheumatol 10: 422-428.
3. Tsubata, T. 2012. Role of inhibitory BCR co-receptors in immunity. Infect. Disord. Drug Targets 12: 181-190.
4. Bolland, S., and J. V. Ravetch. 2000. Spontaneous autoimmune disease in FcgRIIB-deficient mice results from strain-specific epistasis. Immunity 13: 277-285.
5. Kubo, T., Y. Uchida, Y. Watanabe, M. Abe, A. Nakamura, M. Ono, S. Akira, and T. Takai. 2009. Augmented TLR9-induced Btk activation in PIR-B-deficient B-1 cells provokes excessive autoantibody production and autoimmunity. J. Exp. Med. 206: 1971-1982.
6. Li, D. H., M. M. Winslow, T. M. Cao, A. H. Chen, C. R. Davis, E. D. Mellins, P. J. Utz, G. R. Crabtree, and J. R. Parnes. 2008. Modulation of peripheral B cell tolerance by CD72 in a murine model. Arthritis Rheum. 58: 3192-3204.
7. Hibbs, M. L., D. M. Tarlinton, J. Armes, D. Grail, G. Hodgson, R. Maglitto, S. A. Stacker, and A. R. Dunn. 1995. Multiple defects in the immune system of Lyn-deficient mice, culminating in autoimmune disease. Cell 83: 301-311.
8. Pao, L. I., K. P. Lam, J. M. Henderson, J. L. Kutok, M. Alimzhanov, L. Nitschke, M. L. Thomas, B. G. Neel, and K. Rajewsky. 2007. B cell-specific deletion of protein-tyrosine phosphatase Shp1 promotes B-1a cell development and causes systemic autoimmunity. Immunity 27: 35-48.
9. Hoffmann, A., S. Kerr, J. Jellusova, J. Zhang, F. Weisel, U. Wellmann, T. H. Winkler, B. Kneitz, P. R. Crocker, and L. Nitschke. 2007. Siglec-G is a B1 cell-inhibitory receptor that controls expansion and calcium signaling of the B1 cell population. Nat. Immunol. 8: 695-704.
10. Nitschke, L., R. Carsetti, B. Ocker, G. Köhler, and M. C. Lamers. 1997. CD22 is a negative regulator of B-cell receptor signalling. Curr. Biol. 7: 133-143.
11. Otipoby, K. L., K. B. Andersson, K. E. Draves, S. J. Klaus, A. G. Farr, J. D. Kerner, R. M. Perlmutter, C. L. Law, and E. A. Clark. 1996. CD22 regulates thymus-independent responses and the lifespan of B cells. Nature 384: 634-637.
12. Sato, S., A. S. Miller, M. Inaoki, C. B. Bock, P. J. Jansen, M. L. Tang, and T. F. Tedder. 1996. CD22 is both a positive and negative regulator of B lymphocyte antigen receptor signal transduction: altered signaling in CD22-deficient mice. Immunity 5: 551-562.
13. Jellusova, J., U. Wellmann, K. Amann, T. H. Winkler, and L. Nitschke. 2010. CD22 3 Siglec-G double-deficient mice have massively increased B1 cell numbers and develop systemic autoimmunity. J. Immunol. 184: 3618-3627.
14. Bökers, S., A. Urbat, C. Daniel, K. Amann, K. G. Smith, M. Espéli, and L. Nitschke. 2014. Siglec-G deficiency leads to more severe collagen-induced arthritis and earlier onset of lupus-like symptoms in MRL/lpr mice. J. Immunol. 192: 2994-3002.
15. Mary, C., C. Laporte, D. Parzy, M. L. Santiago, F. Stefani, F. Lajaunias, R. M. Parkhouse, T. L. O'Keefe, M. S. Neuberger, S. Izui, and L. Reininger. 2000. Dysregulated expression of the Cd22 gene as a result of a short interspersed nucleotide element insertion in Cd22a lupus-prone mice. J. Immunol. 165: 2987-2996.
16. Cariappa, A., H. Takematsu, H. Liu, S. Diaz, K. Haider, C. Boboila, G. Kalloo, M. Connole, H. N. Shi, N. Varki, et al. 2009. B cell antigen receptor signal strength and peripheral B cell development are regulated by a 9-O-acetyl sialic acid esterase. J. Exp. Med. 206: 125-138.
17. Surolia, I., S. P. Pirnie, V. Chellappa, K. N. Taylor, A. Cariappa, J. Moya, H. Liu, D. W. Bell, D. R. Driscoll, S. Diederichs, et al. 2010. Functionally defective germline variants of sialic acid acetylesterase in autoimmunity. Nature 466: 243-247.
18. Duong, B. H., H. Tian, T. Ota, G. Completo, S. Han, J. L. Vela, M. Ota, M. Kubitz, N. Bovin, J. C. Paulson, and D. Nemazee. 2010. Decoration of Tindependent antigen with ligands for CD22 and Siglec-G can suppress immunity and induce B cell tolerance in vivo. J. Exp. Med. 207: 173-187.
19. Pfrengle, F., M. S. Macauley, N. Kawasaki, and J. C. Paulson. 2013. Copresentation of antigen and ligands of Siglec-G induces B cell tolerance independent of CD22. J. Immunol. 191: 1724-1731.
20. Whitney, G., S. Wang, H. Chang, K. Y. Cheng, P. Lu, X. D. Zhou, W. P. Yang, M. McKinnon, and M. Longphre. 2001. A new siglec family member, siglec-10, is expressed in cells of the immune system and has signaling properties similar to CD33. Eur. J. Biochem. 268: 6083-6096.
21. Hutzler, S., L. Özgör, Y. Naito-Matsui, K. Kläsener, T. H. Winkler, M. Reth, and L. Nitschke. 2014. The ligand-binding domain of Siglec-G is crucial for its selective inhibitory function on B1 cells. J. Immunol. 192: 5406-5414.
22. Muta, T., T. Kurosaki, Z. Misulovin, M. Sanchez, M. C. Nussenzweig, and J. V. Ravetch. 1994. A 13-amino-acid motif in the cytoplasmic domain of FcgRIIB modulates B-cell receptor signalling. Nature 368: 70-73.
23. Ono, M., S. Bolland, P. Tempst, and J. V. Ravetch. 1996. Role of the inositol phosphatase SHIP in negative regulation of the immune system by the receptor FcgRIIB. Nature 383: 263-266.
24. Ono, M., H. Okada, S. Bolland, S. Yanagi, T. Kurosaki, and J. V. Ravetch. 1997. Deletion of SHIP or SHP-1 reveals two distinct pathways for inhibitory signaling. Cell 90: 293-301.
25. Pearse, R. N., T. Kawabe, S. Bolland, R. Guinamard, T. Kurosaki, and J. V. Ravetch. 1999. SHIP recruitment attenuates FcgRIIB-induced B cell apoptosis. Immunity 10: 753-760.
26. Xiang, Z., A. J. Cutler, R. J. Brownlie, K. Fairfax, K. E. Lawlor, E. Severinson, E.U.Walker, R. A. Manz,D.M. Tarlinton, and K. G. Smith. 2007. FcgRIIb controls bone marrow plasma cell persistence and apoptosis. Nat. Immunol. 8: 419-429.
27. Li, F., P. Smith, and J. V. Ravetch. 2014. Inhibitory Fcg receptor is required for the maintenance of tolerance through distinct mechanisms. J. Immunol. 192: 3021-3028.
28. Boross, P., V. L. Arandhara, J. Martin-Ramirez, M. L. Santiago-Raber, F. Carlucci, R. Flierman, J. van der Kaa, C. Breukel, J. W. Claassens, M. Camps, et al. 2011. The inhibiting Fc receptor for IgG, FcgRIIB, is a modifier of autoimmune susceptibility. J. Immunol. 187: 1304-1313.
29. Wandstrat, A. E., C. Nguyen, N. Limaye, A. Y. Chan, S. Subramanian, X. H. Tian, Y. S. Yim, A. Pertsemlidis, H. R. Garner, Jr., L. Morel, and E. K. Wakeland. 2004. Association of extensive polymorphisms in the SLAM/ CD2 gene cluster with murine lupus. Immunity 21: 769-780.
30. Floto, R. A., M. R. Clatworthy, K. R. Heilbronn, D. R. Rosner, P. A. MacAry, A. Rankin, P. J. Lehner, W. H. Ouwehand, J. M. Allen, N. A. Watkins, and K. G. Smith. 2005. Loss of function of a lupus-associated FcgRIIb polymorphism through exclusion from lipid rafts. Nat. Med. 11: 1056-1058.
31. Kono, H., C. Kyogoku, T. Suzuki, N. Tsuchiya, H. Honda, K. Yamamoto, K. Tokunaga, and Z. Honda. 2005. FcgRIIB Ile232Thr transmembrane polymorphism associated with human systemic lupus erythematosus decreases affinity to lipid rafts and attenuates inhibitory effects on B cell receptor signaling. Hum. Mol. Genet. 14: 2881-2892.
32. Willcocks, L. C., E. J. Carr, H. A. Niederer, T. F. Rayner, T. N. Williams, W. Yang, J. A. Scott, B. C. Urban, N. Peshu, T. J. Vyse, et al. 2010. A defunctioning polymorphism in FCGR2B is associated with protection against malaria but susceptibility to systemic lupus erythematosus. Proc. Natl. Acad. Sci. USA 107: 7881-7885.
33. Nimmerjahn, F., and J. V. Ravetch. 2010. Antibody-mediated modulation of immune responses. Immunol. Rev. 236: 265-275.
34. Gerlach, J., S. Ghosh, H. Jumaa, M. Reth, J. Wienands, A. C. Chan, and L. Nitschke. 2003. B cell defects in SLP65/BLNK-deficient mice can be partially corrected by the absence of CD22, an inhibitory coreceptor for BCR signaling. Eur. J. Immunol. 33: 3418-3426.
35. Heidari, Y., A. E. Bygrave, R. J. Rigby, K. L. Rose, M. J. Walport, H. T. Cook, T. J. Vyse, and M. Botto. 2006. Identification of chromosome intervals from 129 and C57BL/6 mouse strains linked to the development of systemic lupus erythematosus. Genes Immun. 7: 592-599.
36. Amezcua Vesely, M. C., M. Schwartz, D. A. Bermejo, C. L. Montes, K. M. Cautivo, A. M. Kalergis, D. J. Rawlings, E. V. Acosta-Rodríguez, and A. Gruppi. 2012. FcgRIIb and BAFF differentially regulate peritoneal B1 cell survival. J. Immunol. 188: 4792-4800.
37. Crotty, S. 2011. Follicular helper CD4 T cells (TFH). Annu. Rev. Immunol. 29: 621-663.
38. Profile Study GroupItalian Collaborative GroupGerman Collaborative Group-Spanish Collaborative GroupArgentinian Collaborative GroupSLEGEN Consortium. 2009. Kallikrein genes are associated with lupus and glomerular basement membrane-specific antibody-induced nephritis in mice and humans. J. Clin. Invest. 119: 911-923.
39. Winter, O., C. Dame, F. Jundt, and F. Hiepe. 2012. Pathogenic long-lived plasma cells and their survival niches in autoimmunity, malignancy, and allergy. J. Immunol. 189: 5105-5111.
40. Jacobi, A. M., and B. Diamond. 2005. Balancing diversity and tolerance: lessons from patients with systemic lupus erythematosus. J. Exp. Med. 202: 341-344.
41. Binder, C. J., P. X. Shaw, M. K. Chang, A. Boullier, K. Hartvigsen, S. Hörkkö, Y. I. Miller, D. A. Woelkers, M. Corr, and J. L. Witztum. 2005. The role of natural antibodies in atherogenesis. J. Lipid Res. 46: 1353-1363.
42. Tarlinton, D. M., M. McLean, and G. J. Nossal. 1995. B1 and B2 cells differ in their potential to switch immunoglobulin isotype. Eur. J. Immunol. 25: 3388-3393.
43. Enghard, P., J. Y. Humrich, V. T. Chu, E. Grussie, F. Hiepe, G. R. Burmester, A. Radbruch, C. Berek, and G. Riemekasten. 2010. Class switching and consecutive loss of dsDNA-reactive B1a B cells from the peritoneal cavity during murine lupus development. Eur. J. Immunol. 40: 1809-1818.
44. Baumgarth, N. 2011. The double life of a B-1 cell: self-reactivity selects for protective effector functions. Nat. Rev. Immunol. 11: 34-46.
45. Bolland, S., Y. S. Yim, K. Tus, E. K. Wakeland, and J. V. Ravetch. 2002. Genetic modifiers of systemic lupus erythematosus in FcgRIIB2/2 mice. J. Exp. Med. 195: 1167-1174.
46. Fukuyama, H., F. Nimmerjahn, and J. V. Ravetch. 2005. The inhibitory Fcg receptor modulates autoimmunity by limiting the accumulation of immunoglobulin G+ anti-DNA plasma cells. Nat. Immunol. 6: 99-106.
47. Lehmann, B., I. Schwab, S. Böhm, A. Lux, M. Biburger, and F. Nimmerjahn. 2012. FcgRIIB: a modulator of cell activation and humoral tolerance. Expert Rev. Clin. Immunol. 8: 243-254.
48. Dörner, T., A. M. Jacobi, and P. E. Lipsky. 2009. B cells in autoimmunity. Arthritis Res. Ther. 11: 247.
49. Khalil, A. M., J. C. Cambier, and M. J. Shlomchik. 2012. B cell receptor signal transduction in the GC is short-circuited by high phosphatase activity. Science 336: 1178-1181.
50. Zhang, Z., T. Goldschmidt, and H. Salter. 2012. Possible allelic structure of IgG2a and IgG2c in mice. Mol. Immunol. 50: 169-171.
51. Barr, T. A., S. Brown, P. Mastroeni, and D. Gray. 2009. B cell intrinsic MyD88 signals drive IFN-g production from T cells and control switching to IgG2c. J. Immunol. 183: 1005-1012.
52. Swanson, C. L., T. J. Wilson, P. Strauch, M. Colonna, R. Pelanda, and R. M. Torres. 2010. Type I IFN enhances follicular B cell contribution to the T cell-independent antibody response. J. Exp. Med. 207: 1485-1500.
53. Morel, L., and E. K. Wakeland. 1998. Susceptibility to lupus nephritis in the NZB/W model system. Curr. Opin. Immunol. 10: 718-725.
54. Rahman, A., and D. A. Isenberg. 2008. Systemic lupus erythematosus. N. Engl. J. Med. 358: 929-939.
55. Espeli, M., S. Bökers, G. Giannico, H. A. Dickinson, V. Bardsley, A. B. Fogo, and K. G. Smith. 2011. Local renal autoantibody production in lupus nephritis. J. Am. Soc. Nephrol. 22: 296-305.
56. Noben-Trauth, N. 2000. Susceptibility to Leishmania major infection in the absence of IL-4. Immunol. Lett. 75: 41-44.
57. Murakami, M., H. Yoshioka, T. Shirai, T. Tsubata, and T. Honjo. 1995. Prevention of autoimmune symptoms in autoimmune-prone mice by elimination of B-1 cells. Int. Immunol. 7: 877-882.